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ABSTRACT 
Objective: Prolonged sitting is increasingly recognized as a ubiquitous cardiometabolic 
risk factor, possibly distinct from lack of physical exercise. We examined whether 
interrupting prolonged sitting with brief bouts of light-intensity activity reduced blood 
pressure (BP) and plasma noradrenaline in type 2 diabetes (T2D).  
Methods: In a randomized crossover trial, 24 inactive overweight/obese adults with T2D 
(14 men; mean±SD; 62±6 y) consumed standardized meals during 3 x 8 h conditions: 
uninterrupted sitting (SIT); sitting + half-hourly bouts of walking (3.2 km.h-1 for 3-min) 
(LW); and, sitting + half-hourly bouts of simple resistance activities for 3-min (SRA), 
each separated by 6-14 days washout. Resting seated BP was measured hourly (mean of 
3 recordings, ≥20-min post-activity). Plasma noradrenaline was measured at 30-min 
intervals for the first hour after meals and hourly thereafter.  
Results: Compared to SIT, mean resting systolic and diastolic BP were significantly 
reduced (P<0.001) for both LW (mean±SEM;-14±1/-8±1 mmHg) and SRA (-16±1/-10±1 
mmHg), with a more pronounced effect for SRA (P<0.05 versus LW). Similarly, mean 
plasma noradrenaline was significantly reduced for both LW (-0.3±0.1 nmol.L-1) and 
SRA (-0.6±0.1 nmol.L-1) versus SIT, with SRA lower than LW (P<0.05). Mean resting 
heart rate was lowered by LW (-3±1 bpm; P<0.05), but not SRA (-1±1 bpm).  
Conclusion: Interrupting prolonged sitting with brief bouts of LW or SRA reduces 
resting BP and plasma noradrenaline in adults with T2D, with SRA being more effective. 
Given the ubiquity of sedentary behaviors and poor adherence to structured exercise, this 
approach may have important implications for BP management in patients with T2D.  
 
Key words: cardiovascular disease prevention, diabetes mellitus, hypertension-high 
blood pressure, sedentary lifestyle, physical activity 
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INTRODUCTION 
Hypertension and type 2 diabetes (T2D) are common comorbidities that substantially 
increase the risk of both micro- and macro-vascular complications [1,2]. Indeed, when 
hypertension coexists with diabetes, the risk of cardiovascular disease is increased by 
some 75%, which further contributes to the overall morbidity and mortality of an already 
high-risk population [2]. As a frontline therapy and adjunct to pharmacotherapy, lifestyle 
interventions – including diet and exercise (30-60 min of continuous or accumulated 
exercise/day and resistance exercises at least 2-3 days/week) – remain cornerstones for 
improving blood pressure (BP), glucose and lipid control [3]. However, despite the 
known benefits, many with T2D remain physically inactive [4] and spend large amounts 
of time in sedentary behaviors (sitting) – defined as any sitting or reclining behavior 
during waking hours with low energy expenditure [(<1.5 Metabolic Equivalents [5,6]]. 
Sedentary behaviors (e.g. TV viewing, other screen time, driving) have been associated 
with higher resting BP [7] and the onset of hypertension [8,9] independent of moderate-
vigorous physical activity, adiposity, age and other common risk factors. This is 
consistent with experimental studies demonstrating an elevation of BP across a 3-5 hour 
period of sitting, with concomitant increases in leg blood pooling and total peripheral 
resistance, as well as reductions in thigh blood flow and endothelial function [10,11]. In 
turn, there is observational and experimental evidence that regularly interrupting 
prolonged periods of sitting can be associated with a more favourable cardiometabolic 
risk profile compared to an equivalent amount of sitting time accumulated in longer, 
uninterrupted bouts [12-16]. Indeed, we recently showed that interrupting sitting time 
with brief intermittent walking bouts improves glycemic control in adults with T2D [15], 
and reduces resting BP in overweight/obese adults [17]. Whether the resting BP benefits 
extend to those with established cardiometabolic disease, such as T2D, remains 
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unknown. Furthermore, no study has examined the utility of interrupting sitting via brief 
bouts of simple resistance-type activities performed in a fixed position, an approach 
which may provide a potent metabolic or cardiovascular stimulus, and offer a pragmatic 
alternative during work tasks or leisure-pursuits where sitting time is frequently accrued.  
Accordingly, we examined the effects of interrupting sitting time with brief bouts of 
light-intensity walking (LW) or simple resistance activities (SRA) on resting BP in adults 
with T2D. Given the known effects of exercise on BP and the sympathetic nervous 
system [18-20], concurrent changes in plasma noradrenaline (NA) were assessed to 
inform about this as a potential candidate mechanism. We hypothesized that resting BP 
and NA levels during prolonged sitting would be attenuated by brief (3 min) intermittent 
bouts of light-intensity physical activity. 
 
METHODS 
Participants 
Non-smoking men and women [body mass index (BMI) 25-40 kg.m2)] aged 35-75 years 
with T2D (diet or Metformin-controlled, HbA1c 6.5-9%) were recruited. Participants 
were excluded if they self-reported sitting <5 hours/day and/or were meeting physical 
activity guidelines (≥150 minutes/week of moderate-intensity exercise). The study was 
approved by the Alfred Human Research Ethics Committee and all participants provided 
written informed consent. 
Study design 
This randomized crossover trial was undertaken at the Baker IDI Heart & Diabetes 
Institute between October 2013 and November 2014. Detailed screening and testing 
procedures have been described previously [15]. In brief, participants attended the 
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laboratory on five separate occasions: 1) medical screening visit; 2) familiarization visit; 
and 3-5) three acute trial condition visits in a randomized order, each separated by 6-14 
days. Trial condition order was randomized by a third party (block-randomization and 
balanced block sizes) and stratified by gender. Power calculations were based on the co-
primary outcomes (postprandial glucose and insulin responses following mixed meals) 
[15], with blood pressure a pre-specified secondary endpoint of the study. Participants 
underwent initial orientation to SRA and LW activities during screening and 
familiarization to ensure the activity interventions could be undertaken safely and 
consistently. 
Experimental protocol 
On trial condition days, participants arrived at the laboratory at 0715 h after a 12 h fast, 
having abstained from caffeine, alcohol, and structured moderate-vigorous physical 
activities (i.e., no physical activity beyond activities of daily living) for 48 h. Each trial 
condition (see Figure 1) commenced with a 60 min ‘steady-state’ period (-1 h to 0 h), 
after which participants consumed standardized breakfast (0 h) and lunch (3.5 h) meals, 
with the time taken to consume (<20 min per meal) replicated in subsequent conditions. 
An indwelling catheter was inserted into an antecubital vein at -1 h and a fasting 
(baseline) sample collected after the steady-state period at 0 h. Following this, 
postprandial samples were collected at 0.5, 1.0, 2.0, 3.5 (pre-lunch), and 4.0, 4.5, 5.5, and 
7.0 h. Participants commenced the following experimental protocols after the breakfast 
meal: A) SIT: uninterrupted sitting; B) LW: sitting interrupted with 3 min bouts of light-
intensity walking (3.2 km.h-1) every 30 min; and, C) SRA: sitting interrupted with 3 min 
bouts of simple resistance activities over 30 min (comprising 20 s body weight half-
squats, 20 s calf raises, 20 s gluteal contractions and knee raises; repeated 3 times in 
sequential order while mimicking a standardized, pre-prepared video recording).  
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INSERT FIGURE 1 ABOUT HERE 
Meals were standardized between conditions and were individualized to each meet 33% 
of daily estimated energy requirements [21] (mean±SEM, 823±25 kcal/meal). The target 
macronutrient profile was 12-15% energy from protein, 55-58% from carbohydrate and 
29-31% from fat. An evening meal pack was also provided for participants to prepare at 
home on the evenings prior to experimental conditions.  
Participants sat upright in a comfortable chair throughout all experimental conditions and 
were instructed to minimize excessive movement, only rising from the chair to void. 
Standardized lavatory visits incorporated into the protocol minimized unscheduled 
physical activity; however, additional lavatory visits were permitted. Participants 
complied with the respective trial condition protocols under direct supervision from 
research staff. They had access to television, DVDs, books, magazines and internet 
services during the trial conditions. Participants completed each experimental trial 
condition in a private clinic room. They were permitted to check emails, but were asked 
to avoid potentially stimulating activities that may influence their BP, such as 
horror/suspense movies, computer gaming and/or gambling. Activity intensity during the 
trial conditions was monitored using heart rate (difference pre- versus post activity-bout) 
and the Borg Rate of Perceived Exertion (RPE; 6-20) scale. As previously reported, the 
difference for heart rate [immediately post-activity bout minus pre; mean±SEM (range: 
min-max)] for the LW and SRA activity-break conditions were 17±1.2 (8-31) and 19±1.0 
(10-30) bpm, and for mean RPE was 9±0.3 (7–12) and 10±0.3 (7-13) points, 
respectively.  
Blood pressure measurement and biochemical analysis 
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Resting BP and heart rate were measured in the seated upright position using an 
automated oscillometric blood pressure monitor (Digital Automatic Blood Pressure 
Monitor HEM-907, Omron, Kyoto, Japan). All measures were taken by trained research 
personnel, using an appropriately sized cuff. The same protocol for BP recordings 
applied at the initial screening/informed consent visit (i.e. average of three consecutive 
measures taken 1 min apart) was followed at each time point of each experimental 
condition (see Figure 1 for specific time points). The sequence of 3 measurements was 
always initiated 10 min before activity bouts. Measurements were taken on the same arm 
for all conditions, contralateral to the arm with the indwelling venous catheter (excepting 
6 participants, for whom the alternate arm was used due to difficulties with the 
cannulation procedure).  
Blood samples for plasma catecholamine determination were drawn into EGTA-
glutathione tubes, centrifuged  within 5 min of collection (2000 rpm for 15 min at 4°C), 
and the plasma stored at -80°C. Plasma NA concentrations were determined by high-
performance liquid chromatography with coulometric detection, following extraction 
from plasma using alumina adsorption [22]. Recoveries of internal standard were used to 
adjust for loss during extraction. Intra-assay and inter-assay coefficients of variation were 
1.3% and 3.8%, respectively. Assays for each individuals’ three visits were completed in 
one assay run. 
Statistical analyses 
Generalized linear mixed models with random intercepts were used to evaluate the 
differential effects of the experimental conditions on the selected outcomes using Stata 
12 (StataCorp LP). Residuals were examined for serial correlation, heteroscedasticity and 
normality. Substantial departures from model assumptions were not observed. A two-tail 
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probability level of 0.05 was adopted. Data are expressed as mean±SEM in text unless 
otherwise stated. Mean BP and plasma NA values (Figure 2; panels c, d and e) were 
quantified as the mean of all timepoints after 0 h. The difference between conditions 
represents the difference in these mean values by condition. All models were adjusted for 
potential covariates explaining residual outcome variance (age, BMI and gender), pre-
prandial/baseline values (mean of timepoints -1 and 0 h for BP and heart rate outcomes, 
and timepoint 0 h for plasma NA) and period effects (treatment order). Time-by-
condition and gender-by-condition interaction tests were performed for both BP and NA. 
Post-hoc analyses were also performed for each outcome to explore the potential 
influence of antihypertensive medications and baseline BP values.  
 
RESULTS 
Participant characteristics  
Twenty-four participants [14 men, 10 women; mean±SD age, 62±6 years; BMI, 33.0±3.4 
kg.m2; HbA1c, 7.2±0.7%; eGFR 87±8 mL.min-1.1.73m-2; diabetes duration 6.8±5.1 years; 
n=23 taking metformin; n=15 taking statins] were randomized and completed all trial 
conditions. They were predominantly pre- or hypertensive (88%), with n=3 (12%) 
normotensive, n=4 (17%) pre-hypertensive, and n=17 (71%) hypertensive [23]. 
Participant attributes were comparable between genders for age, waist circumference and 
baseline BP/metabolic data, however BMI was significantly higher for women 
(mean±SD: 31.5±3.0 versus 35.2±2.8, P<0.05). All participants maintained their baseline 
anti-hypertensive treatment and other medications (Table 1) throughout the course of the 
trial.     
INSERT TABLE 1 ABOUT HERE 
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Resting BP, heart rate and plasma NA responses to prolonged and interrupted 
sitting 
Mean systolic and diastolic BP and plasma NA data over time by trial condition are 
displayed in Figure 2 (panels a and b). Compared to SIT, both LW and SRA reduced 
mean resting systolic and diastolic BP (Figure 2, panels c and d; P<0.001), with the 
effect being more pronounced with SRA (P<0.05 versus LW). Similarly, compared to 
SIT, both LW and SRA were associated with significantly reduced mean plasma NA 
concentrations (Figure 2, panel e), with SRA lower than LW (P<0.043). Changes in 
mean plasma NA and mean systolic and diastolic BP were not significantly correlated 
(P>0.05, data not shown). A small but significantly lower mean resting heart rate was 
observed for LW only (SIT: 79±1; LW: 76±1; SRA: 78±1 bpm, P<0.05). Condition-by-
time interaction effects were observed for both mean systolic and diastolic BP relative to 
the 1 h steady-state period (baseline BP). These demonstrated that during the SIT 
condition, BP was increased 10±1 / 5±1 mmHg (P<0.001) by the end of the day. 
Conversely, within-condition changes for LW and SRA indicated progressive reductions 
in systolic (-10±1 and -12±2 mmHg) and diastolic (-6±1 and -8±1 mmHg) BP by the end 
of the day (both P<0.001). 
INSERT FIGURE 2 ABOUT HERE 
Gender, antihypertensive medications and baseline BP 
A significant gender-by-condition interaction effect was observed for the mean 
difference in systolic BP between conditions SIT and SRA (Supplemental Figure S1); 
indicating that, while still significantly lower for both genders, the magnitude of the 
systolic BP reduction for SRA versus SIT was greater (↓15% versus ↓11%) in women 
than in men. Reductions in all BP and heart rate variables were not influenced by 
antihypertensive medications, however, the magnitude of the mean NA reduction was 
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significantly greater (↓6% versus ↓22%) for SRA compared to SIT in those taking 
antihypertensive medications (Supplemental Figure S1). Treatment with specific 
medications known to increase NA reflexively (i.e. diuretics and/or calcium channel 
blockers) was not associated with differential BP or plasma NA effects (i.e. vs. treatment 
with other antihypertensives and vs. no antihypertensive treatment. The magnitude of the 
difference in mean systolic BP with interrupted sitting tended to be greater in those 
participants with higher baseline systolic BP compared to those with lower baseline 
systolic BP; however, only the SRA-by-baseline systolic BP interaction was statistically 
significant (P=0.046 for SRA, P=0.076 for LW; Supplemental Figure S2). No significant 
interactions were observed for any other outcomes (non-significant data not reported).    
 
DISCUSSION 
The major novel finding of this study is that, in overweight/obese inactive men and 
women with T2D, interrupting prolonged sitting with brief intermittent bouts of either 
light-walking or simple resistance activities acutely reduced resting systolic and diastolic 
BP. This BP differential reflected both a progressive elevation in BP from baseline in the 
prolonged sitting condition and a progressive reduction in BP during the activity bout 
conditions. The BP-lowering effects on both activity days were paralleled by a significant 
reduction in plasma NA levels, although changes in systolic and diastolic BP and NA 
were not significantly correlated. Moreover, the magnitude of reductions in BP and NA 
were significantly greater with the simple resistance activities compared to the light 
walking. The present results extend recent findings in overweight/obese adults [17] by 
demonstrating the potential hypotensive effects of interrupting prolonged sitting in 
patients with T2D – which, if sustained, are comparable to that of monotherapy with 
many common anti-hypertensive drugs [24].  
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Evidence on the duration and intensity required for optimal BP reduction with 
accumulated activity bouts is limited, and less is known about the antihypertensive 
effects of even shorter (<10 min) bouts of light-intensity physical activity. Miyashita and 
colleagues showed that accumulating 30 min of brisk walking [25] or running [26] in 3 
min bouts interspersed throughout the day was as effective as a 30 min continuous bout 
of similar intensity in reducing acute and second day systolic BP in young 
normotensive/pre-hypertensive men. Interestingly, the BP reduction observed for the 
intermittent running bout condition was no greater than walking bouts, despite increases 
in intensity and energy expended, which was similar to findings in sedentary adults [27]. 
It was also recently reported in overweight/obese adults that accumulating 2.5 h of 
standing or light-intensity physical activity during an 8-h workday equally improved 
ambulatory BP during and after work hours, compared to prolonged sitting [28]. These 
data and ours are congruent with previous literature regarding a light-intensity physical 
activity ‘threshold’ for blood pressure lowering [3,29], which may even be related to 
simple postural change. It is possible that the increased intensity and/or compound nature 
of the skeletal muscle contractile activity associated with the simple resistance activities 
evoked a stronger muscle pressor reflex, with greater post-activity vasodilatation in the 
absence of a compensatory increase in cardiac output, potentially contributing to lower 
NA and BP [30,31]. These factors, along with the optimal mode, frequency, duration and 
intensity of very short activity bouts for blood pressure control in T2D and hypertensive 
patients, should be examined in future studies. 
Consistent with previous evidence on the influence of continuous exercise on BP-
lowering [3], participants with higher baseline systolic BP generally showed a more 
pronounced reduction in systolic BP during the physical activity conditions, relative to 
prolonged sitting. The increased magnitude of BP reduction during the simple resistance 
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activity condition for women compared to men, while intriguing and consistent with 
epidemiological findings that have documented gender differences in the associations of 
television viewing time with cardiometabolic risk biomarkers [32,33], is challenging to 
explain. We did not observe significant changes in heart rate, oxygen consumption, 
perceived exertion or plasma NA levels (stratified data not reported) for women 
compared to men, which may have formed a plausible basis for these gender variations. 
It should also be noted that all women were post-menopausal (although not significantly 
older than the men) and were not taking hormone replacement therapy. Differences in 
adipose and lean body mass or other biological disparities between men and women with 
T2D could be the potential basis for gender differences.  
The mechanisms accounting for the reported blood pressure reductions with interrupted 
versus uninterrupted sitting are likely to be multiple [3,34]. Lower sympathetic nerve 
activity is the most salient feature of post-exercise hypotension [18,19] which may 
contribute to reductions in both cardiac output and total peripheral resistance. A role for 
this mechanism is supported by our observation of reduced plasma NA levels during the 
activity bout conditions, although more direct indices of sympathetic nervous system 
activity would be required for definitive proof. Interestingly, any reductions in 
sympathetic nervous system activity may either be a direct consequence of the 
interrupted sitting intervention, or secondary to reductions in plasma insulin [15,35,36]. 
Further, evidence suggests that interruptions in sitting time may promote endothelial-
dependent vasodilation via increased arterial shear stress secondary to activity-related 
blood flow and heart rate elevation [37,38]. Although direct measurements of blood flow, 
cardiac output and/or sympathetic activity would have compromised the present study 
design, such measures, or more sophisticated tracer techniques to address whether 
13 
 
neurotransmitter levels were a result of decreased clearance or increased release, would 
be highly informative in future studies. 
Strengths of this study include: the well-controlled randomized cross-over study design, 
allowing for within and between participant comparisons and a smaller sample size; the 
standardized trial condition lead-in periods, with strict but pragmatic control of 
confounder variables such as diet, physical activity, and fasting metabolic levels; hourly 
blood pressure assessment using automated serial measurements; and, full retention of 
participants. The potential efficacy of an alternative, simple and practical form of sitting 
interruption (brief bouts of simple resistance activities) was also demonstrated, 
suggesting that the benefits associated with sitting interruptions may not be limited to 
only those involving ambulatory activities. Given the acute nature of this trial, we can 
only speculate on possible longer term exposures. It is also possible that the BP 
reductions observed in this study may be smaller if the sitting (control) condition was 
more reflective of free-living conditions. As such, assessment of ambulatory blood 
pressure over consecutive days under free-living scenarios would be an important next 
step. Finally, further research is needed to determine whether effects can be generalized 
to other populations – including the non-obese, pre-menopausal women, and less well-
controlled T2D patients (i.e. insulin-dependent with beta cell dysfunction) – who may 
have differing levels of sympathetic activation; and, identify whether the approach we 
have tested is feasible and beneficial for those limited physically by diabetic 
complications or by other co-morbidities. 
We have shown that interrupting prolonged sitting with brief light walking or simple 
resistance activity bouts acutely reduces resting BP and plasma NA levels in adults with 
T2D, most of whom were also hypertensive. Thus, interrupting prolonged sitting may be 
a practical strategy that could contribute towards minimizing the risk of micro- and 
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macrovascular complications in T2D patients. Although longer term efficacy needs to be 
established, our findings provide the first experimental evidence in T2D patients 
demonstrating the beneficial impact of interrupting prolonged sitting with brief 
intermittent activity bouts for blood pressure control. With these caveats in mind, we 
therefore propose that healthcare professionals consider advising their patients on 
regularly interrupting prolonged sitting time, in addition to promoting the well-
established benefits of moderate-vigorous and leisure-time physical activity.  
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FIGURE LEGENDS 
Figure 1. Experimental day protocol for each trial condition with meal consumption and 
measurement time-points. Thick vertical lines in the grey bars for conditions B and C 
show the timing of the light-walking (LW) and simple resistance activity (SRA) 
interruptions from uninterrupted sitting (SIT). The vertical striped section in the grey bars 
from -1 to 0 h denotes the sitting ‘steady-state’ period. Blood pressure and blood 
collection were recorded at 10 min and 1 min prior to activity bouts, respectively, during 
the LW and SRA conditions.  
 
Figure 2. The effect of uninterrupted sitting (SIT), and sitting interrupted with 3-min 
light-intensity walking (LW) and simple-resistance activity (SRA) bouts on mean±SEM 
resting systolic (SBP) and diastolic (DBP) blood pressure (a) and plasma noradrenaline 
(NA) (b) levels over time. Panels c, d and e represent marginal means±SEM (i.e. averaged 
values for all timepoints after 0 h, adjusted for age, BMI, gender, fasting levels, and 
treatment order) for SBP, DBP and plasma NA per condition, respectively. Vertical 
dashed lines in panels a and b indicate the timing of the breakfast (0 h) and lunch (3.5 h) 
meals. Values within the bars (panels c, d and e) denote to the mean mmHg or percentage 
change compared to SIT. *Difference from SIT (P<0.05). †SRA different from LW 
(P<0.05). 
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Table 1. Participant clinical characteristics and medications  
Metabolic and cardiovascular risk factors   
 
Systolic blood pressure (mmHg) 123 ± 14 
 
Diastolic blood pressure (mmHg) 77 ± 9  
 
Fasting total cholesterol (mmol.L-1) 4.4 ± 0.8  
 
Fasting LDL-cholesterol (mmol.L-1) 2.5 ± 0.8  
 
Fasting HDL-cholesterol (mmol.L-1) 1.1 ± 0.3  
 
Fasting triglycerides (mmol.L-1) 1.9 ± 1.0  
 
Fasting glucose (mmol.L-1) 8.2 ± 1.4  
Concomitant medications 
 
 
Metformin 23 (96%) 
 
Statin 15 (63%) 
 
Anti-depressants (SSRI or SNRI) 4 (17%) 
 
Anti-hypertensive 16 (67%) 
  
ACE inhibitor or ARB 16 (67%) 
  
Calcium channel blocker 5 (21%) 
  
Beta blocker 2 (8%) 
    Thiazide diuretic 11 (46%) 
 
Data are mean±SD or number (%). SSRI, Selective serotonin reuptake inhibitor; SNRI, 
Serotonin and norepinephrine reuptake inhibitor; ACE, Angiotensin converting enzyme; 
ARB, Angiotensin II receptor blocker. Note: blood pressure measurements were 
collected during the screening visit. Fasting metabolic measurements were collected at 
the beginning of the first trial condition. 
 
 
 
